INDIA LIVE DESKNIFTY 50:23,140.50(+0.34%)SENSEX:73,895.74(+0.43%)
RDU Global
🇮🇳
Home/Topics/Companies & Institutions/Medico Remedies
Back to Newsroom
🏢Organization Dossier

Medico Remedies

Curated news coverage, institutional background, regulatory filings, and investigative reporting across RDU Global.

7 Stories Indexed
Last Updated: Just Now
Verified Entity Intelligence
Healthcare, Pharma & Life Sciences Just now (07:19 PM IST)

Medico Remedies Among Five Healthcare Stocks to Hit 52-Week Lows as Sensex Slips 242 Points

Indian healthcare counters came under renewed pressure on Thursday, with five BSE Healthcare Index stocks touching fresh 52-week lows as the Sensex fell 242 points to 72,529. Medico Remedies, Pfizer, AstraZeneca Pharma India, Sanofi Consumer Healthcare India and Eris Lifesciences all marked their weakest levels in a year, underscoring the depth of the sector’s recent correction. Several of these names have now shed as much as 48% in a month, reflecting sustained selling in defensive pockets of the market.

By RDU Global Wire4 min read
National Governance & Policy14 Oct 2026, 07:12 AM IST

Hospitals, Police Withhold Medico-Legal Records as Protest Injured Seek Proof of Detention Abuse

Hospitals and police are refusing to readily share medico-legal case records with people injured while in detention, forcing patients to move between institutions in search of documents that could substantiate allegations of custodial abuse. Sources say hospitals often record injuries but are under pressure not to release the information during periods of protest, raising concerns over transparency, accountability, and access to justice.

5 min readRead →
National Governance & Policy18 Nov 2026, 08:00 AM IST

Kerala High Court Rejects Lawyer’s Bid for Contempt Action Against Judge

The Kerala High Court has dismissed a lawyer’s plea seeking contempt proceedings against a judge, underscoring the limits of such extraordinary remedies and the need to distinguish personal grievance from judicial misconduct. The court also observed that the petitioner’s standing as a lawyer was not in doubt and advised her not to be unduly concerned by social media commentary.

5 min readRead →
Macro Economy & Fiscal Policy11 Nov 2026, 08:00 AM IST

India Opens Anti-Dumping Probe Into Aluminium Imports From China, Malaysia and Vietnam

India’s trade remedies authority has launched a suo motu investigation into alleged dumping of aluminium products from China, Malaysia and Vietnam, after domestic manufacturers warned that a flood of low-priced imports is eroding margins and threatening production. The move signals heightened scrutiny of import pricing in a sector where small and medium-sized units say they are being squeezed by unfair competition.

6 min readRead →
Macro Economy & Fiscal Policy08 Nov 2026, 08:00 PM IST

DGTR Recommends Two-Year Import Curbs on Soda Ash to Shield Domestic Producers

India’s Directorate General of Trade Remedies has recommended two years of import restrictions on soda ash, including country-wise allocations and quarterly shipment limits, in a move aimed at protecting domestic manufacturers from import pressure. The proposal is designed to moderate inflows while giving local producers time to adjust capacity, pricing, and market share in a sector critical to glass, detergents, and chemicals.

6 min readRead →
National Governance & Policy02 Nov 2026, 02:00 PM IST

Rural Development Ministry Notifies Grievance Redress Rules Under VB-G Ram Ji Act, 2026

India’s Ministry of Rural Development has formally notified the Grievance Redress Rules, 2026 under the VB-G Ram Ji Act, marking a significant step in the government’s effort to tighten accountability in rural governance. The new framework is expected to standardize complaint handling, strengthen timelines for resolution, and improve citizen access to administrative remedies across rural development programmes.

5 min readRead →
Banking, Fintech & Insurance25 Oct 2026, 08:00 PM IST

Yes Bank Weighs Capital Moves as Supreme Court Ruling Pressures CET1

Yes Bank said it is evaluating capital-raising and other strategic options after a Supreme Court ruling is expected to reduce its Common Equity Tier 1 capital by reversing the 2020 write-down of additional Tier 1 bonds. The lender said its growth priorities remain intact, even as it assesses legal remedies and the financial impact of the judgment.

5 min readRead →

🏢 About this Entity

Corporations, startups, regulatory bodies, central banks, ministries and judicial courts. All news mentioning this entity is automatically verified and aggregated into this live intelligence dossier.

Co-Occurring Entities

Entities frequently referenced alongside Medico Remedies: